For the Inventor, By the Inventor

Enter assignee name

Burnaby, Canada

Alectos Therapeutics Inc.

USPTO Granted Patents = 18

CIPO Patents = 3

EPO Patents = 14

Forward Citations = 43

Loading Chart...

Loading Chart...

20 inventors (with patents filed for the assignee):

Yuanxi Zhou (16 out of 40 patents)

Ernest John McEachern (15 out of 43 patents)

Harold G Selnick (15 out of 102 patents)

4. David Jaro Vocadlo (14 out of 21 patents)

5. Yongbao Zhu (9 out of 18 patents)

6. Ramesh Kaul (7 out of 11 patents)

7. Kun Liu (5 out of 48 patents)

8. Jianyu Sun (4 out of 24 patents)

9. Yaode Wang (4 out of 10 patents)

10. Zhongyong Wei (4 out of 8 patents)

11. Tong-Shuang Li (4 out of 9 patents)

12. Changwei Mu (3 out of 8 patents)

13. Jiang Chang (2 out of 15 patents)

14. Ernest J Mceachern (2 out of 2 patents)

15. Samy Cecioni (1 out of 1 patent)

18 patents: Sort by Forward Citations

1. 11396522 - Bis-acetal-based substrates for imaging exo-glycosidase activity (2022-07-26),

2. 10913733 - Substituted piperidines thiazolyl acetamides as glycosidase inhibitors and uses thereof (2021-02-09),

3. 10081601 - Glucocerebrosidase modulators and uses thereof (2018-09-25),

4. 9938299 - Glycosidase inhibitors and uses thereof (2018-04-10),

5. 9815861 - Selective glycosidase inhibitors and uses thereof (2017-11-14),

6. 9809537 - Glycosidase inhibitors and uses thereof (2017-11-07),

7. 9796680 - Glucocerebrosidase modulators and uses thereof (2017-10-24),

8. 9718854 - Selective glycosidase inhibitors and uses thereof (2017-08-01),

9. 9701693 - Selective glycosidase inhibitors and uses thereof (2017-07-11),

10. 9695197 - Glycosidase inhibitors and uses thereof (2017-07-04),

11. 9670195 - Glycosidase inhibitors and uses thereof (2017-06-06),

12. 9611275 - Permeable glycosidase inhibitors and uses thereof (2017-04-04),

13. 9522883 - Glycosidase inhibitors and uses thereof (2016-12-20),

14. 9409924 - Selective glycosidase inhibitors and uses thereof (2016-08-09),

15. 9243020 - Selective glycosidase inhibitors and uses thereof (2016-01-26),

ALECTOS THERAPEUTICS INC. is a biopharmaceutical company dedicated to discovering and developing innovative drugs for the treatment of neurodegenerative diseases. With a focus on targeting protein misfolding and aggregation, ALECTOS aims to provide transformative therapies to patients suffering from Alzheimer's, Parkinson's, and other related disorders. Through a combination of cutting-edge research, strategic partnerships, and a passionate team of scientists, ALECTOS is committed to making a positive impact on the lives of millions affected by debilitating neurodegenerative conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

18 Patents

#21 in Burnaby

#779 in Canada

#33,199 in the World

Burnaby, Canada

Alectos Therapeutics Inc.

Forward Citations = 43

20 inventors:

Yuanxi Zhou (16 out of 40 patents)

Ernest John McEachern (15 out of 43 patents)

Harold G Selnick (15 out of 102 patents)

4. David Jaro Vocadlo (14 out of 21 patents)

5. Yongbao Zhu (9 out of 18 patents)

Please report any incorrect information to support@idiyas.com

Loading…